Ailing Liang - Search Results

Year	Number of Results
2009	1
2010	1
2011	1
2013	1
2015	2
2016	2
2017	1
2019	3
2020	3
2021	2
2022	1
2023	3
2024	0

1

MiR-17- 5p/RRM2 regulated gemcitabine resistance in lung cancer A549 cells.

Ma X, Fu T, Ke ZY, Du SL, Wang XC, Zhou N, Zhong MY, Liu YJ, Liang AL. Ma X, et al. Cell Cycle. 2023 Jun;22(11):1367-1379. doi: 10.1080/15384101.2023.2207247. Epub 2023 Apr 28. Cell Cycle. 2023. PMID: 37115505 Free PMC article.

2

[Role of P21 in Resistance of Lung Cancer].

Fu T, Liang A, Liu Y. Fu T, et al. Among authors: liang a. Zhongguo Fei Ai Za Zhi. 2020 Jul 20;23(7):597-602. doi: 10.3779/j.issn.1009-3419.2020.101.16. Epub 2020 May 21. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32434295 Free PMC article. Review. Chinese.

3

Research progress on the relationship between lung cancer drug-resistance and microRNAs.

Ma X, Liang AL, Liu YJ. Ma X, et al. J Cancer. 2019 Nov 17;10(27):6865-6875. doi: 10.7150/jca.31952. eCollection 2019. J Cancer. 2019. PMID: 31839821 Free PMC article. Review.

4

[Cell Cycle Checkpoint Kinase and Drug Resistance of Lung Cancer].

Ke Z, Liang A, Liu Y. Ke Z, et al. Among authors: liang a. Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):265-270. doi: 10.3779/j.issn.1009-3419.2021.101.09. Zhongguo Fei Ai Za Zhi. 2021. PMID: 33910274 Free PMC article. Review. Chinese.

5

Structures of MPND Reveal the Molecular Recognition of Nucleosomes.

Yang M, Li X, Tian Z, Ma L, Ma J, Liu Y, Shang G, Liang A, Wu W, Chen Z. Yang M, et al. Among authors: liang a. Int J Mol Sci. 2023 Feb 8;24(4):3368. doi: 10.3390/ijms24043368. Int J Mol Sci. 2023. PMID: 36834777 Free PMC article.

6

A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis.

Zeng YS, Peng J, Gao XF, Tian D, Zhan W, Liu J, Hu XJ, Huang S, Tian ST, Qiu L, Liang AL, Wang FY, Dong RH, Guang B, Yang T. Zeng YS, et al. Eur J Pharmacol. 2022 Dec 15;937:175381. doi: 10.1016/j.ejphar.2022.175381. Epub 2022 Nov 8. Eur J Pharmacol. 2022. PMID: 36368417

7

MiRNA-10b sponge: An anti-breast cancer study in vitro.

Liang AL, Zhang TT, Zhou N, Wu CY, Lin MH, Liu YJ. Liang AL, et al. Oncol Rep. 2016 Apr;35(4):1950-8. doi: 10.3892/or.2016.4596. Epub 2016 Jan 26. Oncol Rep. 2016. PMID: 26820121 Free PMC article.

8

p21 promotes gemcitabine tolerance in A549 cells by inhibiting DNA damage and altering the cell cycle.

Fu T, Ma X, Du SL, Ke ZY, Wang XC, Yin HH, Wang WX, Liu YJ, Liang AL. Fu T, et al. Oncol Lett. 2023 Sep 20;26(5):471. doi: 10.3892/ol.2023.14059. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37809050 Free PMC article.

9

Functional and structural investigation of a novel β-mannanase BaMan113A from Bacillus sp. N16-5.

Liu W, Ma C, Liu W, Zheng Y, Chen CC, Liang A, Luo X, Li Z, Ma W, Song Y, Guo RT, Zhang T. Liu W, et al. Among authors: liang a. Int J Biol Macromol. 2021 Jul 1;182:899-909. doi: 10.1016/j.ijbiomac.2021.04.075. Epub 2021 Apr 15. Int J Biol Macromol. 2021. PMID: 33865894

10

Screening miRNAs associated with resistance gemcitabine from exosomes in A549 lung cancer cells.

Liang AL, Du SL, Zhang B, Zhang J, Ma X, Wu CY, Liu YJ. Liang AL, et al. Cancer Manag Res. 2019 Jul 8;11:6311-6321. doi: 10.2147/CMAR.S209149. eCollection 2019. Cancer Manag Res. 2019. PMID: 31372037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year